Bill Snyder

Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction. Read More

Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world. Read More

Jonathan Seidman, Ph.D., who has made pivotal contributions to understanding the genetic basis of cardiomyopathy and other heart diseases, will deliver the next Flexner Discovery Lecture on Thursday, March 14. Read More

Individuals with overexpression of the gene MECP2 have core features of autism spectrum disorder. Read More

Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer. Read More

Top chemists from around the country will be on hand March 12 to celebrate the 10th anniversary of the Vanderbilt Institute of Chemical Biology (VICB), a brave experiment that helped jumpstart the University’s robust drug discovery initiative. Read More

Diabetes has a big impact on the brain. Read More

“Brain Blast,” a half-day of free, hands-on activities for children and adults will be held from 9 a.m. to 1 p.m., Saturday, March 2, at Vanderbilt Health One Hundred Oaks. Read More

It’s possible to cure Chagas disease – a deadly tropical infection transmitted by “kissing bugs” – in a mouse model. Read More

As is the case throughout the country, this year’s flu season in Middle Tennessee is hitting elderly people particularly hard. Read More

C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21. Read More

Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity. Read More

Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years. Read More

One of the critical, unmet needs for people with autism spectrum disorder (ASD) is support for the transition into adulthood. Read More

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop. Read More

ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies. Read More

Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

F. Peter (Fred) Guengerich, Ph.D., Stanford Moore Professor of Biochemistry, is the 2013 recipient of the Society of Toxicology Merit Award in recognition of distinguished achievements to toxicology throughout his career. Read More

Seven seniors in the School for Science and Math at Vanderbilt (SSMV) made it to the semifinalist level in the Intel Science Talent Search 2013. Read More

Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea. Read More